Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-19

Clinical Trial Update: Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache. [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether topiramate can prevent episodic migraine from converting into chronic daily headache; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topamax (Topiramate)

Snippet

Sponsor: Ortho-McNeil Neurologics, Inc. | Conditions: Migraine, Headache | Phase 4 | Status: COMPLETED